Picture of ASAHI KASEI logo

3407 — ASAHI KASEI News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapSuper Stock

Brief: Asahi Kasei, Axolabs Partners To Accelerate Oligonucleotide Therapeutics Development

April 11 (Reuters) - Asahi Kasei Bioprocess and Axolabs:
    * ASAHI KASEI BIOPROCESS AND AXOLABS ANNOUNCE STRATEGIC
PARTNERSHIP TO ACCELERATE OLIGONUCLEOTIDE THERAPEUTICS
DEVELOPMENT

Source text for Eikon:  ID:nBw5WrCdca 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ASAHI KASEI

See all news